back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2026-03-18 17:49 Tx date 2026-03-18 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Geyer, Paul
4 - Director of Issuer
Holder: PNG Enterprise Foundation (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-162,000
-15,000 vol $10.80 each |
33,725 | |
| Filed 2026-03-18 17:48 Tx date 2026-03-18 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Geyer, Paul
4 - Director of Issuer
Holder: PNG Enterprise Foundation (Control or Direction)
|
Common Shares
54 - Exercise of warrants
|
$146,175
+48,725 vol $3.00 each |
48,725 | |
| Filed 2026-03-18 17:46 Tx date 2021-03-08 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Geyer, Paul
4 - Director of Issuer
Holder: PNG Enterprise Foundation (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2026-03-18 17:44 Tx date 2026-03-18 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Geyer, Paul
4 - Director of Issuer
Holder: PNG Enterprise Foundation (Control or Direction)
|
Warrants
54 - Exercise of warrants
|
$-146,175
-48,725 vol $3.00 each |
0 | |
| Filed 2026-03-16 22:19 Tx date 2026-03-16 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Geyer, Paul
4 - Director of Issuer
Direct Ownership
|
Warrants
11 - Acquisition or disposition carried out privately
|
$-146,175
-48,725 vol $3.00 each |
0 | |
| Filed 2026-03-16 22:18 Tx date 2026-03-16 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Geyer, Paul
4 - Director of Issuer
Holder: PNG Enterprise Foundation (Control or Direction)
|
Warrants
11 - Acquisition or disposition carried out privately
|
$146,175
+48,725 vol $3.00 each |
48,725 | |
| Filed 2026-03-16 22:13 Tx date 2021-03-08 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Geyer, Paul
4 - Director of Issuer
Holder: PNG Family Foundation (Control or Direction)
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2026-03-16 22:12 Tx date 2021-03-08 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Geyer, Paul
4 - Director of Issuer
Holder: PNG Enterprise Foundation (Control or Direction)
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2026-03-16 22:09 Tx date 2021-03-08 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Geyer, Paul
4 - Director of Issuer
Holder: PNG Family Foundation (Control or Direction)
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2026-03-10 17:20 Tx date 2026-03-09 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Geyer, Paul
4 - Director of Issuer
Holder: Quimby Investments (VCC) Ltd. (Control or Direction)
|
Warrants
55 - Expiration of warrants
|
$-140,000
-12,500 vol $11.20 each |
0 | |
| Filed 2025-12-22 12:48 Tx date 2025-12-15 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Geyer, Paul
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Stock Unit
56 - Grant of rights
|
$86,300
+10,000 vol $8.63 each |
10,000 | |
| Filed 2025-12-19 20:01 Tx date 2025-12-15 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Geyer, Paul
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Stock Unit
56 - Grant of rights
|
$86,300
+10,000 vol $8.63 each |
||
| Filed 2025-12-19 20:02 Tx date 2025-12-15 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Geyer, Paul
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$172,600
+20,000 vol $8.63 each |
238,750 | |
| Filed 2025-12-19 20:01 Tx date 2025-12-15 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Geyer, Paul
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Stock Unit
56 - Grant of rights
|
$86,300
+10,000 vol $8.63 each |
10,000 | |
| Filed 2025-12-19 20:00 Tx date 2021-03-08 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Geyer, Paul
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Stock Unit
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2025-11-07 19:39 Tx date 2025-11-02 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Geyer, Paul
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-100,000
-12,500 vol $8.00 each |
218,750 | |
| Filed 2025-08-11 19:18 Tx date 2025-05-13 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Geyer, Paul
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$135,500
+25,000 vol $5.42 each |
231,250 | |
| Filed 2025-04-14 13:55 Tx date 2025-03-31 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Geyer, Paul
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-200,000
-25,000 vol $8.00 each |
206,250 | |
| Filed 2025-03-27 13:56 Tx date 2025-03-25 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Geyer, Paul
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$231,300
+45,000 vol $5.14 each |
231,250 | |
| Filed 2024-05-22 23:13 Tx date 2024-05-13 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Geyer, Paul
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$178,200
+45,000 vol $3.96 each |
186,250 |